Health Canada has issued a recall involving two lots of Allerject (0.15 mg / 0.15 mL auto-injector) products due to a manufacturing error that could be preventing the product from working properly. The recalled Allerject medication was distributed by Sanofi-aventis Canada Inc. since June 1, 2015 and the lot numbers in question are 2857508, 2857505 and DIN 02382059.

Allerject is typically used in the emergency treatment of anaphylaxis in children and works by reversing the rapid and dangerous decrease in blood pressure and relaxing the muscles in the airway during an allergic reaction. The manufacturing defect may prevent the product from working, and serious anaphylaxis may cause death if not immediately treated. Parents with the affected Allerject products are advised to take them to their pharmacy for replacements as soon as possible.

Click here to read more about this Health Canada recall.